Meiqi Feng
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Harnessing tumor acidity: innovative lactic acid-responsive promoter enables precision control of CAR-T cell activity in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: January 28, 2026
Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice.
Journal: Communications medicine
Published: May 08, 2024
Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.
Journal: Cell discovery
Published: May 01, 2023
Corrigendum: A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice.
Journal: Frontiers in immunology
Published: January 17, 2023
A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice.
Journal: Frontiers in immunology
Published: November 16, 2022
Rapid generation of a mouse model for evaluating on-target normal tissue toxicity of human CAR-T cells using replication-defective recombinant adenovirus.
Journal: Journal of advanced research
Published: November 18, 2021
Hsa-miR-31 Governs T-Cell Homeostasis in HIV Protection via IFN-γ-Stat1-T-Bet Axis.
Journal: Frontiers in immunology
Published: September 06, 2021
Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026